glp-1 risk dvt Can Ozempic Cause Blood Clots? [2026 Update] GLP-1 Agonists in Cardiovascular Diseases:

Key highlights Microdosing is defined as using very small, off-label doses that are far below standard therapeutic doses to get mild benefits with fewer side effects

Ten GLP-1RAs induced a significantly higher risk of vomiting than placebo: ITCA 650, CagriSema, orforglipron, efpeglenatide, tirzepatide, lixisenatide, semaglutide, liraglutide, exenatide, and dulaglutide (fig 8D)

Subgroup analyses indicated reduced risks of colorectal cancer (HR 0.81: 95% CI: 0.680.96) and liver cancer (HR: 0.74

The prospective validation of a scoring system to assess mucosal cleanliness during EGD

Burra P, Becchetti C, Germani G

Key genetic variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) predict which patients achieve optimal weight loss with standard dosing versus those requiring higher doses or different compounds